美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

NervGen Pharma Corp.

2.06

-0.0800-3.74%

盤後：2.05-0.0092-0.45%18:44 EDT

成交量：80.74萬

成交額：170.05萬

市值：2.18億

市盈率：-4.58

高：2.20

開：2.10

低：2.05

收：2.14

52周最高：6.30

52周最低：1.70

股本：1.06億

流通股本：9,418.02萬

量比：0.81

換手率：0.86%

股息：- -

股息率：- -

每股收益(TTM):-0.4500

每股收益(LYR):-0.4448

淨資產收益率：-1207.46%

總資產收益率：-90.75%

市淨率：56.05

市盈率(LYR):-4.63

資料載入中...

總覽公司新聞公告

NervGen Pharma Corp - Nvg-291在1B/2a期Connect Sci研究中顯示出統計學顯著的步態質量改善

熱門話題-NervGen Pharma因發行股票及認股權證而股價暴跌

NervGen Pharma Corp啓動普通股、認股權證及預融資認股權證承銷公開發行

NervGen Pharma 公司——淨收益將用於推進Nvg-291臨床研究及一般公司用途

NervGen藥業任命基思·文多拉為首席財務官，強化領導團隊實力

BUZZ--美國股票走勢-醫療保險公司、Arista、Savara

NervGen Pharma Corp. 即將完成1B/2a期CONNECT-SCI亞急性四肢癱患者入組並揭盲數據

NervGen Pharma宣佈成功完成二期臨床試驗結束會議，並與FDA就慢性四肢癱瘓治療藥物Nvg-291的三期註冊研究"Restore"達成共識

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/NGEN/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NGEN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NGEN\",,,,,undefined,":{"symbol":"NGEN","market":"US","secType":"STK","nameCN":"NervGen Pharma Corp.","latestPrice":2.06,"timestamp":1782244800000,"preClose":2.14,"halted":0,"volume":807365,"hourTrading":{"tag":"盘后","latestPrice":2.0508,"preClose":2.06,"latestTime":"18:44 EDT","volume":2209,"amount":4539.977,"timestamp":1782254640017,"change":-0.0092,"changeRate":-0.004466,"amplitude":0.016505},"delay":0,"changeRate":-0.03738317757009349,"floatShares":94180200,"shares":106000000,"eps":-0.45,"marketStatus":"未開盤","change":-0.08,"latestTime":"06-23 16:00:00 EDT","open":2.1,"high":2.2,"low":2.05,"amount":1700507.5255870002,"amplitude":0.070093,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.45,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1782288000000},"marketStatusCode":0,"adr":0,"exchange":"NASDAQ","adjPreClose":2.14,"preHourTrading":{"tag":"盘前","latestPrice":2.16,"preClose":2.14,"latestTime":"09:19 EDT","volume":205,"amount":450.87972649999995,"timestamp":1782220783417,"change":0.02,"changeRate":0.009346,"amplitude":0.023224},"postHourTrading":{"tag":"盘后","latestPrice":2.0508,"preClose":2.06,"latestTime":"18:44 EDT","volume":2209,"amount":4539.977,"timestamp":1782254640017,"change":-0.0092,"changeRate":-0.004466,"amplitude":0.016505},"volumeRatio":0.807312,"impliedVol":0.2913,"impliedVolPercentile":0.1238},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NGEN\",,,,,undefined,":{"symbol":"NGEN","floatShares":94180200,"roa":"-90.75%","roe":"-1207.46%","lyrEps":-0.444846,"volumeRatio":0.807312,"shares":106000000,"dividePrice":0,"high":2.2,"amplitude":0.070093,"preClose":2.14,"low":2.05,"week52Low":1.7,"pbRate":"56.05","week52High":6.3,"institutionHeld":0,"latestPrice":2.06,"eps":-0.45,"divideRate":0,"volume":807365,"delay":0,"ttmEps":-0.45,"open":2.1,"prevYearClose":5.6,"prevWeekClose":2.2,"prevMonthClose":2.07,"prevQuarterClose":3.77,"fiveDayClose":1.86,"twentyDayClose":2.08,"sixtyDayClose":3.66},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NGEN\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-05-15","symbol":"NGEN","fiscalQuarterEnding":"2026/03","expectedEps":-0.07,"name":null,"time":"盤後","type":"earning","dateTimestamp":1778817600000,"reportTimeType":"post","actualEps":-0.09},{"date":"2026-03-31","symbol":"NGEN","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774944000000,"name":null,"time":"盤前","dateTimestamp":1774929600000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NGEN\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NGEN\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":8,"updateTime":1781236800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/NGEN\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"NGEN","date":"2026-06-22","current":-4.539945,"percent":0.837838,"low":-25.148356,"twenty":-17.852833,"median":-15.828582,"eighty":-9.350047,"high":-6.149004,"avg":-13.879145,"sd":5.297229,"marketCap":233646899},"quantilePoints":[{"date":"2026-01-09","current":-25.148356,"twenty":-24.98651,"median":-24.743741,"eighty":-24.500973,"marketCap":463798962.95},{"date":"2026-01-16","current":-23.484013,"twenty":-24.651705,"median":-24.262661,"eighty":-23.546305,"marketCap":432253265.53},{"date":"2026-01-23","current":-22.238177,"twenty":-24.339127,"median":-23.484013,"eighty":-22.456198,"marketCap":412101315.23},{"date":"2026-01-30","current":-17.441707,"twenty":-24.262661,"median":-22.611928,"eighty":-20.307131,"marketCap":329508465.32},{"date":"2026-02-06","current":-16.382746,"twenty":-23.795472,"median":-22.238177,"eighty":-17.908896,"marketCap":306238051.42},{"date":"2026-02-13","current":-17.441707,"twenty":-23.484013,"median":-19.886661,"eighty":-17.285978,"marketCap":327197651.85},{"date":"2026-02-20","current":-18.220355,"twenty":-23.359429,"median":-18.282647,"eighty":-17.285978,"marketCap":340388899.6},{"date":"2026-02-27","current":-17.753166,"twenty":-22.879782,"median":-18.03348,"eighty":-17.410561,"marketCap":331850071.27},{"date":"2026-03-06","current":-17.223686,"twenty":-22.51849,"median":-17.893323,"eighty":-17.27352,"marketCap":321208516.98},{"date":"2026-03-13","current":-16.382746,"twenty":-22.306698,"median":-17.753166,"eighty":-16.993207,"marketCap":307553178.63},{"date":"2026-03-20","current":-16.957011,"twenty":-22.250635,"median":-17.753166,"eighty":-16.888553,"marketCap":316207550},{"date":"2026-03-27","current":-15.785094,"twenty":-21.714925,"median":-17.597437,"eighty":-16.837477,"marketCap":291516280},{"date":"2026-04-02","current":-18.89617,"twenty":-20.942507,"median":-17.535145,"eighty":-16.702393,"marketCap":347270760},{"date":"2026-04-10","current":-10.676925,"twenty":-19.970755,"median":-17.441707,"eighty":-16.494872,"marketCap":340718966},{"date":"2026-04-17","current":-10.464421,"twenty":-19.238183,"median":-17.254832,"eighty":-16.110604,"marketCap":336672423},{"date":"2026-04-24","current":-9.863583,"twenty":-18.837636,"median":-17.005665,"eighty":-12.953446,"marketCap":318058323},{"date":"2026-05-01","current":-9.064424,"twenty":-18.587877,"median":-16.950192,"eighty":-10.62677,"marketCap":293779061},{"date":"2026-05-08","current":-9.632569,"twenty":-18.344939,"median":-16.86331,"eighty":-10.287304,"marketCap":311583853},{"date":"2026-05-15","current":-9.34654,"twenty":-18.295105,"median":-16.834362,"eighty":-10.043494,"marketCap":300253531},{"date":"2026-05-22","current":-9.812417,"twenty":-18.145605,"median":-16.66306,"eighty":-9.800918,"marketCap":297825605},{"date":"2026-05-29","current":-7.287863,"twenty":-18.008563,"median":-16.66306,"eighty":-9.72533,"marketCap":220902522},{"date":"2026-06-05","current":-7.091826,"twenty":-17.902667,"median":-16.382746,"eighty":-9.634252,"marketCap":213468303},{"date":"2026-06-12","current":-6.717699,"twenty":-17.87775,"median":-16.216296,"eighty":-9.423447,"marketCap":200723927},{"date":"2026-06-18","current":-7.855923,"twenty":-17.87775,"median":-15.872071,"eighty":-9.364073,"marketCap":232584867},{"date":"2026-06-22","current":-7.907765,"twenty":-17.852833,"median":-15.828582,"eighty":-9.350047,"marketCap":233646899}],"updateTime":1782267445952},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NGEN\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1133039688","title":"NervGen Pharma Corp - Nvg-291在1B/2a期Connect Sci研究中顯示出統計學顯著的步態質量改善","url":"https://stock-news.laohu8.com/highlight/detail?id=1133039688","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1133039688?lang=zh_tw&edition=fundamental","pubTime":"2026-05-26 19:16","pubTimestamp":1779794209,"startTime":"0","endTime":"0","summary":"NervGen Pharma Corp. 宣布，其研究性药物Nvg-291在针对多发性硬化症患者的1B/2a期Connect Sci临床研究中，取得了具有统计学显著意义的步态质量改善。研究数据显示，与安慰剂组相比，接受Nvg-291治疗的患者在步态分析的关键指标上表现出显著提升。Nvg-291是一种旨在促进神经修复和功能恢复的新型疗法。公司表示，将继续推进相关临床开发计划，以进一步评估Nvg-291在更广泛神经系统适应症中的安全性与有效性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","NGEN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637237354","title":"熱門話題-NervGen Pharma因發行股票及認股權證而股價暴跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2637237354","media":"路透中文","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637237354?lang=zh_tw&edition=fundamental","pubTime":"2026-05-22 04:29","pubTimestamp":1779395349,"startTime":"0","endTime":"0","summary":"由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"37684715aaf54a73b9fe52ee56a263cc","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260521:nL4T41Y24J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","NGEN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1174712044","title":"NervGen Pharma Corp啓動普通股、認股權證及預融資認股權證承銷公開發行","url":"https://stock-news.laohu8.com/highlight/detail?id=1174712044","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1174712044?lang=zh_tw&edition=fundamental","pubTime":"2026-05-22 04:04","pubTimestamp":1779393853,"startTime":"0","endTime":"0","summary":"NervGen Pharma Corp.宣布，公司已启动一项承销公开发行，将发行普通股、认股权证及预融资认股权证。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","NGEN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1102911496","title":"NervGen Pharma 公司——淨收益將用於推進Nvg-291臨床研究及一般公司用途","url":"https://stock-news.laohu8.com/highlight/detail?id=1102911496","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1102911496?lang=zh_tw&edition=fundamental","pubTime":"2026-05-22 04:04","pubTimestamp":1779393852,"startTime":"0","endTime":"0","summary":"NervGen Pharma 公司宣布，此次融资所得净收益将主要用于推进其核心候选药物Nvg-291的临床研究，并支持公司的一般运营与战略发展。此举旨在加速该疗法的开发进程，为未来的商业化奠定基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","NGEN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1118353180","title":"NervGen藥業任命基思·文多拉為首席財務官，強化領導團隊實力","url":"https://stock-news.laohu8.com/highlight/detail?id=1118353180","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1118353180?lang=zh_tw&edition=fundamental","pubTime":"2026-04-27 19:35","pubTimestamp":1777289732,"startTime":"0","endTime":"0","summary":"NervGen药业公司宣布任命基思·文多拉担任首席财务官，这一关键人事变动将显著增强公司的领导团队架构。此次高层调整旨在优化企业财务战略布局，为后续业务拓展提供强有力的支持。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NGEN","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625953047","title":"BUZZ--美國股票走勢-醫療保險公司、Arista、Savara","url":"https://stock-news.laohu8.com/highlight/detail?id=2625953047","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625953047?lang=zh_tw&edition=fundamental","pubTime":"2026-04-07 21:08","pubTimestamp":1775567334,"startTime":"0","endTime":"0","summary":".N** 博通公司AVGO.O：BUZZ - 因与谷歌达成开发定制人工智能芯片的长期协议而在盘前上涨  nL4N40Q0HL ** CVS Health Corp CVS.N：** UnitedHealth Group Inc UNH.N：** Elevance Health Inc ELV.N：BUZZ - 美国最终确定将医疗保险优势支付上调 2.48%，医疗保险公司大涨 nL4N40Q0I3 ** Greenwich LifeSciences Inc GLSI.O:BUZZ - 新数据扩大了潜在的乳腺癌药物市场，导致该公司股价上涨。nL4N40Q0PW ** Humana Inc HUM.N:BUZZ - 因医疗保险费率上调而跳涨；富国银行上调评级   nL4N40Q0R7 ** Old Dominion Freight Line Inc ODFL.OODFL.O:BUZZ - 因需求前景强劲，富国银行将其评级上调至 \"等权重\"。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"37684715aaf54a73b9fe52ee56a263cc","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260407:nL4T40Q0YR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MNR","LU1551013425.SGD","LU0187121727.USD","LU1244550494.USD","LU0175139822.USD","LU0820561909.HKD","LU0708995401.HKD","LU1934455863.HKD","LU2279689827.SGD","LU1244550577.SGD","LU2491050071.SGD","LU1323610961.USD","HUM","LU0210536198.USD","LU1934455277.USD","LU1074936037.SGD","SG9999015945.SGD","LU1814569148.SGD","IE0001KFT4U8.USD","LU2420271590.USD","LU1153585028.USD","LU2746668974.SGD","LU0128525929.USD","LU0211327993.USD","SG9999014906.USD","HALO","LU1791710582.SGD","LU0256331488.USD","SG9999015986.USD","LU0203347892.USD","LU1069347547.HKD","LU2168564222.USD","IE00B8L5B284.USD","IE00BYV24P56.USD","LU0079474960.USD","BK4588","LU0208291251.USD","LU2168564149.EUR","LU0149725797.USD","LU1571399168.USD","LU2106854487.HKD","LU0203345920.USD","LU0082616367.USD","LU1878469433.USD","LU2065169927.USD","LU2720916845.USD","IE00B3PB1722.GBP","AVGX","LU0143863198.USD","LU2112291526.USD","LU0130517989.USD","LU2456880835.USD","IE00BK4W5M84.HKD","LU0784383803.USD","LU0742534661.SGD","UNH","LU0266013472.USD","LU1989764664.SGD","LU1815336760.USD","LU2133065610.SGD","SGXZ31699556.SGD","LU1989771016.USD","LU0823416689.USD","BK4082","LU0784385840.USD","LU2168564495.EUR","BK4139","IE00BGHQF631.EUR","LU0053666078.USD","LU0114720955.EUR","LU0289961442.SGD","LU0980610538.SGD","LU1983260115.SGD","IE0008368304.USD","LU1674673691.USD","IE0009356076.USD","LU0348723411.USD","LU0057025933.USD","LU0942090050.USD","LU1670711040.USD","LU0050427557.USD","LU2491049909.HKD","LU2463526074.USD","BK4022","LU2347655073.USD","LU1935042215.USD","LU2250418816.HKD","ELV","LU0210535034.USD","LU0211331839.USD","LU2360032135.SGD","LU0069063385.USD","LU2065171402.SGD","LU1989764748.USD","LU2087625088.SGD","IE00BK4W5L77.USD","BK4179","LU2237443978.SGD","BK4554","LU0868494708.USD","LU0077335932.USD","LU0354030511.USD","LU0912757837.SGD","LU1868838027.USD","LU0642271901.SGD","IE00B19Z3581.USD","LU0861579265.USD","IE00B775SV38.USD","LU0154245756.USD","CLYM","LU0130102774.USD","LU2265009873.SGD","BK4548","LU0795875169.SGD","LU2244417387.USD","LU1670627923.USD","LU0496365809.HKD","LU1868837300.USD","LU1989772840.SGD","LU1804176565.USD","LU0256863902.USD","NBIX","BK4605","BK4550","LU0320765489.SGD","IE0004445239.USD","IE00B2B36J28.USD","IE00BZ9MQY76.HKD","LU2468319806.SGD","LU2236285917.USD","LU0545039389.USD","LU1934455194.USD","IE00BSNM7G36.USD","LU0162691827.USD","LU2237438978.USD","AVGO","LU2491050154.USD","LU2092937221.SGD","BK4187","LU2063271972.USD","IE00B19Z8W00.USD","SG9999017495.SGD","LU1003077747.HKD","LU0476273544.USD","LU1778281490.HKD","GB00BDT5M118.USD","SG9999015952.SGD","LU1923623000.USD","LU1861217088.USD","LU2362541513.USD","IE00BFSS8Q28.SGD","LU0345768153.USD","LU0143863784.USD","LU1093756168.USD","IE00BZ1G4Q59.USD","LU2463028550.USD","LU1623119135.USD","LU0708994859.HKD","IE00BJJMRZ35.SGD","LU1291159041.SGD","AVL","LU2471134523.USD","IE00BBT3K403.USD","LU1280957306.USD","SGXZ99366536.SGD","LU1551013342.USD","LU2505996509.AUD","LU1691799644.USD","SG9999015978.USD","LU0274383776.USD","GD","LU1720051017.SGD","BK4113","SG9999001176.SGD","LU2097829019.USD","LU0390134368.USD","LU0683600562.USD","LU2750360641.GBP","IE00BN0W2T93.GBP","IE00BWXC8680.SGD","LU0251142724.SGD","LU2125909593.SGD","LU0052756011.USD","IE00B7SZLL34.SGD","LU0456842615.SGD","LU0061475181.USD","BKR","LU1242518857.USD","LU1261432733.SGD","LU0444971666.USD","LU2360108059.USD","IE00B1B80R65.USD","LU2213496289.HKD","IE00BMPRXN33.USD","LU0158827781.USD","LU0234572021.USD","NGEN","IE00BMPRXQ63.HKD","IE00BQXX3F31.USD","IE00BJJMRX11.SGD","IE00BLSP4239.USD","LU0124676726.USD","LU2290526834.HKD","LU1366333091.USD","LU0006306889.USD","SGXZ51526630.SGD","LU2756315664.SGD","AVS","IE00BFTCPJ56.SGD","LU1057294990.SGD","LU1316542783.SGD","IE0002270589.USD","LU0238689110.USD","BK4512","LU2430703095.HKD","LU0157215616.USD","LU0672654240.SGD","LU0868494617.USD","LU1712237335.SGD","LU2237443465.HKD","LU0784385170.HKD","LU0943347566.SGD","LU1868836757.USD","LU0823434583.USD","LU0964807845.USD","LU2089984988.USD","LU1301847155.USD","LU0107464264.USD","LU2461242641.AUD","LU0345770308.USD","LU0081259029.USD","LU0154236417.USD","LU1119994496.HKD","LU2089283258.USD","LU0965509283.SGD","LU0553294199.USD","IE00BKPKM429.USD","LU1059921491.USD","IE00B1BXHZ80.USD","BK4020","LU0072461881.USD","LU2089985449.USD","LU1069344957.HKD","LU0310799852.SGD","LU0251132253.USD","KMLI","LU0557290698.USD","LU0048573561.USD","LU1868837136.USD","SGXZ23171101.USD","IE00B19Z3B42.SGD","LU2417539215.USD","IE0034235303.USD","LU2362540622.SGD","LU0068578508.USD","LU0314104364.USD","LU2458330243.SGD","ODFL","IE00B19Z4B17.USD","LU0417517546.SGD","LU2552382215.SGD","IE00B19Z9505.USD","LU0053671581.USD","LU2361044865.SGD","CNQ","LU1084165304.USD","LU2125154935.USD","LU0128525689.USD","LU2125154778.USD","LU0965508806.USD","LU1803068979.SGD","LU1935042488.USD","IE00B7KXQ091.USD","IE00BDGV0183.EUR","LU0029864427.USD","LU2756315318.SGD","LU2324357040.USD","LU0433182093.SGD","LU2764262908.HKD","LU2272731782.SGD","LU0648001328.SGD","LU2264538146.SGD","LU1093756325.SGD","BK4581","LU0345769128.USD","BK4141","LU0320765992.SGD","LU2896262040.SGD","LU2237443622.USD","LU0511384066.AUD","LU0053687314.USD","IE0005OL40V9.USD","IE00BN8TJ469.HKD","LU2089284900.SGD","BK4213","IE0004445015.USD","LU1035775433.USD","LU1242518931.SGD","LU2023251221.USD","LU0820562030.AUD","LU1127390331.HKD","IE0009355771.USD","LU2272731600.USD","LU2931357623.SGD","LU2347655156.SGD","LU0097036916.USD","SG9999002224.SGD","AORT","SG9999018865.SGD","BK4154","LU0456855351.SGD","LU0109394709.USD","LU1868836591.USD","SG9999001440.SGD","LU1868836914.USD","LU2471134879.HKD","LU0949170772.SGD","LU1935043023.USD","LU0795875086.SGD","BK4232","BK4216","LU2355687059.USD","LU0094547139.USD","LU1066053197.SGD","LU2505996681.GBP","LU0158827948.USD","LU0256863811.USD","LU0976567544.SGD","LU2322448791.USD","LU0056508442.USD","GLSI","LU1267930227.SGD","LU2272731865.HKD","LU2237443382.USD","IE00BFXG1179.USD","CF","SG9999003800.SGD","LU0784384876.USD","BK4007","IE00B775H168.HKD","LU0203201768.USD","LU1868837722.USD","LU2764263039.SGD","IE00B4JS1V06.HKD","SGXZ81514606.USD","LU0320765059.SGD","BK4564","LU0127658192.USD","LU0080751232.USD","IE00B0169N27.USD","LU0210528500.USD","LU0823434740.USD","IE00BN0W2V16.EUR","LU2211814178.USD","LU0820561818.USD","LU0689626769.HKD","IE00BKVL7J92.USD","LU0719512351.SGD","SGXZ57979304.SGD","SG9999014914.USD","LU0477156953.USD","SG9999014005.SGD","BK4171","IE00BQXX3C00.GBP","LU1854103824.USD","LU0289960550.SGD","LU2041044095.USD","BK4533","LU2471134796.USD","LU2271345857.HKD","LU2322448957.HKD","LU1037948897.HKD","BK4575","LU0061474960.USD","LU1720051108.HKD","IE00BJLML261.HKD","LU1861215975.USD","LU1974910355.USD","SG9999018857.SGD","LU2168564065.EUR","LU0096364046.USD","IE00B7SZL793.SGD","LU2023250504.SGD","BK4551","LU0342679015.USD","LU0314106906.USD","LU1670710588.SGD","LU1951200564.SGD","LU2357305700.SGD","MELI","BK4598","SG9999001424.SGD","LU0949170426.SGD","IE00BN29S564.USD","SG9999014013.SGD","LU0211326839.USD","LU2242649171.HKD","LU0957808578.USD","LU1674673428.USD","LU1699723380.USD","LU1732799900.SGD","LU1988902786.USD","BK4093","LU0528227936.USD","LU0979878070.USD","LU0006061336.USD","IE00B19Z9Z06.USD","SG9999013999.USD","AVGU","XPOF","IE0009354923.USD","LU0323591593.USD","IE00B8HQ1Z84.USD","BK4539","LU2023250843.SGD","LU1064131342.USD","LU0726765562.USD","IE0031619046.USD","LU0070302665.USD","LU0661504455.SGD","LU2023250330.USD","LU2279701549.SGD","LU1861220033.SGD","LU2360106780.USD","BK4196","LU2462157665.USD","LU0211328371.USD","LU1992135472.HKD","SG9999011175.SGD","LU2168563687.JPY","LU1506573853.SGD","LU2552382132.HKD","IE00BGHQDM52.EUR","IE00BFSS7M15.SGD","AVGW","LU2247934214.USD","IE00B66KJ199.SGD","LU2360107168.USD","LU0354030438.USD","LU0215105999.USD","LU2361044949.HKD","IE00BVYPNW00.USD","LU0198837287.USD","LU0234570918.USD","LU1267930490.SGD","LU2237443549.SGD","IE00B42XCP33.USD","LU2602419157.SGD","BK4534","LU1145028129.USD","LU0532187761.SGD","LU0823411888.USD","IE00B4R5TH58.HKD","IE00BLSP4452.SGD","LU0011850046.USD","LU0965509101.SGD","LU0310800379.SGD","SVRA","LU0106261372.USD","LU2108987350.USD","IE0002141913.USD","LU2065170008.USD","LU0109391861.USD","SG9999014021.USD","LU2237957902.USD","LU2125909247.SGD","LU0444973449.USD","LU1854104046.USD","LU2083900584.USD","LU0432979614.USD","LU0868486357.SGD","LU2286300806.USD","LU0878866978.SGD","IE000M9KFDE8.USD","IE00BVYPNV92.GBP","LU0106959298.USD","LU1201861249.SGD","LU0738911758.USD","LU0096362180.USD","LU0345768740.USD","BK4543","LU1815333072.USD","LU2360107671.USD","LU0689472784.USD","LU2473716301.USD","LU1489326972.SGD","LU2543165471.USD","AVGG","LU2746668461.USD","LU0048584097.USD","IE00B19Z8X17.USD","BK4585","LU2764263203.CNY","LU1935042991.SGD","CGON","IE00BJJMRY28.SGD","LU0122379950.USD","LU2361045086.USD","UNHW","LU1244550221.USD","LU2458330169.SGD","LU0345769631.USD","LU0210533765.USD","LU1035773651.USD","IE00BJTD4N35.SGD","LU0786609619.USD","LU2237443895.HKD","LU2028103732.USD","IE00B0JY6N72.USD","LU0965509010.AUD","LU1983299246.USD","IE00B894F039.SGD","LU1670711123.USD","LU1037948541.HKD","LU2430703178.SGD","LU2860962120.EUR","LU0353189680.USD","LU0310800965.SGD","LU1061106388.HKD","BK4220","LU1267930573.SGD","LU1642822529.SGD","UNHG","LU2362541273.HKD","LU2211815571.USD","BK4562","LU0211326755.USD","SG9999002232.USD","LU0882574055.USD","IE00B1XK9C88.USD","CASY","LU0203202063.USD","SG9999014880.SGD","IE00BJTD4V19.USD","LU2242650005.HKD","LU2065171311.SGD","LU2592432038.USD","BK4532","LU1861220207.SGD","LU1923622614.USD","LU0985489474.SGD","LU0289739699.SGD","SG9999001176.USD","LU0225283273.USD","LU0640476718.USD","LU2403377893.USD","BK4566","LU0289739343.SGD","IE00BKDWB100.SGD","LU0431992006.USD","LU1366192091.USD","LU1914381329.SGD","LU2237957811.SGD","LU1232071149.USD","LU1732800096.USD","LU0472753341.HKD","LU1852331112.SGD","LU2054465674.USD","SPCE","LU1162221912.USD","LU2487616109.SGD","LU2298321311.HKD","LU1868837565.USD","LU2471134952.CNY","LU1718418525.SGD","LU2552382058.USD","BK4504","LU0320765646.SGD","LU0889565916.HKD","IE00BMPRXR70.SGD","LU1935043536.SGD","IE00BJT1NW94.SGD","BK4516","SG9999014898.SGD","LU1791710400.SGD","BK4515","LU2430703251.USD","IE00B19Z9P08.USD","CVS","LU0251131958.USD","IE00B3S45H60.SGD","LU1066051498.USD","BK4122","LU0889565833.HKD","LU2750360997.AUD","ANET","BK4612","LU0353189763.USD","IE00BMCWC346.EUR","LU0985320562.USD","LU0957791311.USD","LU0170899867.USD","LU2433249047.HKD","LU1917777945.USD","ORGO","IE00BVYPNQ40.USD","LU0058720904.USD","LU1951198990.SGD","LU0316494557.USD","SG9999001077.SGD","LU1066051225.USD","FENC","LU1670628061.USD","IE0034235188.USD","LU2111349929.HKD","LU0154245673.USD","LU1023059063.AUD","LU1670710661.SGD","LU1066051811.HKD","LU0466842654.USD","LU0345770993.USD","LU1496350502.SGD","LU1989772923.USD","LU1992135399.USD","SG9999004303.SGD","LU0109392836.USD","LU1548497426.USD","LU0787776722.HKD","LU1629891620.HKD","PSTV","IE00BVYPNP33.GBP","LU1267930730.SGD","IE00B5949003.HKD","IE00BGV7N243.SGD","IE00BN0W2W23.USD","IE00BQXX3D17.EUR"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1130972687","title":"NervGen Pharma Corp. 即將完成1B/2a期CONNECT-SCI亞急性四肢癱患者入組並揭盲數據","url":"https://stock-news.laohu8.com/highlight/detail?id=1130972687","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1130972687?lang=zh_tw&edition=fundamental","pubTime":"2026-04-07 19:31","pubTimestamp":1775561476,"startTime":"0","endTime":"0","summary":"NervGen Pharma Corp. 宣布，其针对亚急性脊髓损伤导致四肢瘫患者的1B/2a期CONNECT-SCI临床试验即将完成患者入组工作。随着这一关键节点的达成，公司下一步将着手进行数据揭盲，以评估其候选药物的有效性与安全性。这一进展标志着该药物在神经修复领域的临床开发迈出了重要一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NGEN","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193065506","title":"NervGen Pharma宣佈成功完成二期臨床試驗結束會議，並與FDA就慢性四肢癱瘓治療藥物Nvg-291的三期註冊研究\"Restore\"達成共識","url":"https://stock-news.laohu8.com/highlight/detail?id=1193065506","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1193065506?lang=zh_tw&edition=fundamental","pubTime":"2026-04-07 19:31","pubTimestamp":1775561476,"startTime":"0","endTime":"0","summary":"NervGen Pharma Corp. 近日宣布，已成功完成针对其候选药物Nvg-291用于治疗慢性四肢瘫痪的三期注册研究\"Restore\"的二期临床试验结束会议。此次会议取得了积极成果，公司与美国食品药品监督管理局（FDA）就三期研究的整体开发计划达成了一致。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","NGEN"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":8,"code":"91000000","status":"200"}]}}